We are thrilled to announce an opening for a postdoctoral research fellow to join our UK Platform of Nucleic Acid Therapy for rare disease treatment (UPNAT) Node at University College London (UCL).
This position is supported by the Medical Research Council and NIHR (National Institute for Health and Care Research) and offers a unique opportunity to develop a strategic framework for identifying rare disease-associated variants amenable to Nucleic Acid Therapeutics (NATs).
The role offers the appointed individual a unique opportunity to develop a strategic framework to identify rare disease-associated variants amendable to NATs. The research fellow will be mentored by a diverse range of expert researchers, clinician scientists and bioinformaticians, alongside benefiting part of a rich collaborative network. The research fellow will also get the opportunity to develop pre-clinical NAT targets using a broad range of molecular and cell biology-based approaches. The postdoctoral research fellow will be responsible for conducting experiments on executing genetic data analysis with investigators and databases associated with UPNAT, and testing NATs designed for the targets selected by the Target Selection Working Group in the Node. The post will be allocated in the Zhou lab at the Great Ormond Street Institute of Child Health (GOSICH), full time for 2 years with possibility of extension.
Closing date: 30 July 2024
